Skip to main content

Regeneron

Regeneron, headquartered in the United States, is a publicly listed biotechnology company that invents, develops and commercialises medicines for serious diseases. Leveraging proprietary VelociSuite® technologies, the firm builds and advances therapies across eye conditions, allergy and inflammation, cancer, cardiovascular/metabolic and rare-disease areas. Regeneron’s integrated R&D and technology platforms support its mission of translating science into medicine.

North America
Pharmaceuticals & Biotechnology
Public
Not Engaged
Visit Website
ACT Core
F Non-mature
Just Transition
6.7/100
Nature Benchmark
15.0/100
Social Benchmark
24.1/100
Gender Assessment
21.8/100
On this page

Subscribe to stay informed on our work

Keep up to date with all the latest from World Benchmarking Alliance

Join our newsletter